Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors.
Phan, J., Steadman, D.J., Koli, S., Ding, W.C., Minor, W., Dunlap, R.B., Berger, S.H., Lebioda, L.(2001) J Biol Chem 276: 14170-14177
- PubMed: 11278511 
- DOI: 10.1074/jbc.M009493200
- Primary Citation of Related Structures:  
1HW3, 1HW4 - PubMed Abstract: 
Thymidylate synthase (TS) is a major target in the chemotherapy of colorectal cancer and some other neoplasms. The emergence of resistance to the treatment is often related to the increased levels of TS in cancer cells, which have been linked to the elimination of TS binding to its own mRNA upon drug binding, a feedback regulatory mechanism, and/or to the increased stability to intracellular degradation of TS ...